BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.881
EU - Europa 6.170
AS - Asia 5.116
SA - Sud America 673
Continente sconosciuto - Info sul continente non disponibili 219
AF - Africa 128
OC - Oceania 22
Totale 26.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.637
IT - Italia 2.043
GB - Regno Unito 1.958
CN - Cina 1.339
SG - Singapore 1.288
HK - Hong Kong 647
VN - Vietnam 506
BR - Brasile 487
SE - Svezia 439
DE - Germania 343
BD - Bangladesh 303
TR - Turchia 276
UA - Ucraina 240
FI - Finlandia 232
RU - Federazione Russa 224
FR - Francia 222
IN - India 178
KR - Corea 166
CA - Canada 125
BG - Bulgaria 88
NL - Olanda 73
AR - Argentina 63
MX - Messico 55
IE - Irlanda 50
IQ - Iraq 50
JP - Giappone 50
ID - Indonesia 46
ES - Italia 39
PK - Pakistan 36
PL - Polonia 34
IR - Iran 33
ZA - Sudafrica 33
CO - Colombia 29
BE - Belgio 28
RO - Romania 28
AE - Emirati Arabi Uniti 26
EC - Ecuador 25
MY - Malesia 20
IL - Israele 19
VE - Venezuela 19
CH - Svizzera 17
EG - Egitto 17
AU - Australia 16
CL - Cile 16
LT - Lituania 16
UZ - Uzbekistan 16
DZ - Algeria 15
GR - Grecia 14
MA - Marocco 14
SA - Arabia Saudita 14
CZ - Repubblica Ceca 12
JO - Giordania 12
PY - Paraguay 12
KE - Kenya 11
PT - Portogallo 11
CR - Costa Rica 10
JM - Giamaica 10
KZ - Kazakistan 10
PH - Filippine 10
TN - Tunisia 10
TW - Taiwan 10
EU - Europa 9
HN - Honduras 9
AZ - Azerbaigian 8
EE - Estonia 8
PE - Perù 8
RS - Serbia 8
AT - Austria 7
HU - Ungheria 7
PR - Porto Rico 7
UY - Uruguay 7
BO - Bolivia 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
NP - Nepal 6
NZ - Nuova Zelanda 6
ET - Etiopia 5
KH - Cambogia 5
NO - Norvegia 5
OM - Oman 5
TT - Trinidad e Tobago 5
AL - Albania 4
BY - Bielorussia 4
BZ - Belize 4
LK - Sri Lanka 4
NG - Nigeria 4
NI - Nicaragua 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
CY - Cipro 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
PS - Palestinian Territory 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
Totale 25.965
Salva come PNG Salva come JPEG
Città #
Ashburn 1.724
Southend 1.526
Fairfield 1.079
Santa Clara 1.056
Singapore 787
Woodbridge 706
Chandler 649
Hong Kong 638
San Jose 517
Houston 463
Jacksonville 460
Seattle 448
Wilmington 447
Chicago 436
Council Bluffs 398
Dearborn 387
Ann Arbor 379
Cambridge 375
Beijing 338
Hefei 331
Nyköping 282
Los Angeles 276
Modena 236
London 230
Ho Chi Minh City 177
Izmir 158
Milan 152
New York 149
Helsinki 146
The Dalles 137
Seoul 121
Salt Lake City 100
Rome 94
Hanoi 92
Princeton 91
San Diego 84
Sofia 83
Dallas 80
Eugene 80
Buffalo 69
Columbus 67
Lauterbourg 62
Moscow 58
Bologna 57
Redwood City 53
São Paulo 52
Fremont 48
Elk Grove Village 47
Falls Church 47
Shanghai 47
Tampa 46
Phoenix 45
Orem 42
Tokyo 42
Chennai 38
Dublin 36
Munich 36
Bremen 35
Frankfurt am Main 34
Naples 33
Florence 28
Jakarta 28
Toronto 28
Como 27
Boardman 26
Napoli 26
Palermo 25
Brussels 24
Des Moines 24
Guangzhou 24
Lancaster 23
Reggio Emilia 23
Atlanta 22
Brooklyn 22
San Giuliano Milanese 22
Da Nang 21
Tulare 21
Mexico City 20
Montreal 20
Miami 19
Catania 18
Sterling 18
Turin 18
Warsaw 18
Baghdad 17
Genoa 17
Manchester 17
Bari 16
Johannesburg 16
Norwalk 16
Parma 16
Stockholm 16
Kocaeli 15
Nanjing 15
New Delhi 15
Pittsburgh 15
Denver 14
Detroit 14
Dulles 14
Perugia 14
Totale 17.698
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 616
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 548
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 494
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 470
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 455
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 436
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 434
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 433
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 432
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 425
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 424
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 418
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 415
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 409
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 395
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 386
Nanoparticle transport across the blood brain barrier 386
Nanomedicine: the future for advancing medicine and neuroscience 384
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 382
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 379
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 378
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 374
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 371
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 371
Protein corona and nanoparticles: How can we investigate on? 369
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 366
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 365
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 359
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 354
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 353
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 351
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 351
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 348
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 346
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 344
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 341
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 341
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 339
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 337
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 335
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 330
Functionalization of liposomes: microscopical methods for preformulative screening 328
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 328
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 325
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 318
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 317
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 315
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 293
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 293
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 287
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 285
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 284
Immunonanosystems to CNS pathologies: State of the art 283
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 281
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 275
Nanotechnology and Central Nervous System Drug Delivery 273
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 272
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 268
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 266
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 266
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 263
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 263
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 257
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 251
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 249
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 245
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 235
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 233
Leptin-conjugated nanoparticles as drug delivery system to the brain 229
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 223
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 221
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 211
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 209
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 202
Nanomedicine in neurodegenerative disorders: Understanding the journey 201
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 190
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 187
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 176
Nanotechnology in medicine: therapeutic strategies in neurological disorders 174
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 150
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 139
Totale 26.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.268 0 0 0 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/20253.723 170 54 62 287 765 520 279 307 335 161 354 429
2025/20267.232 436 214 456 876 1.382 473 738 330 698 731 444 454
2026/20271.782 159 452 671 500 0 0 0 0 0 0 0 0
Totale 26.209